TOG Review (RCOG Journal)

MRCOG Part 2

Sexual and Reproductive Health

A review of contraceptive methods for women with cardiac disease

Key Statistics

  • 17–33% — Maternal mortality, pulmonary hypertension (2009 SR)
  • 99.8% — LNG-IUS efficacy yr 1 (> sterilisation 99.5%)
  • 1–2/1000 — Uterine perforation risk at IUD/IUS insertion

Don't-miss facts

  1. Cardiac disease = leading indirect cause of UK maternal death; pregnancy contraindicated (class 4) in pulmonary hypertension, severe heart failure, severe left heart obstruction

  2. COC UKMEC 4: personal VTE history, impaired cardiac function/heart failure, atrial fibrillation, ischaemic heart disease, previous ischaemic stroke, migraine with aura, BP ≥160/≥100. Avoid estrogen in cyanotic heart disease and mechanical valves

  3. POP is suitable for almost any woman — no ↑VTE, hypertension, stroke or MI risk; exception is bosentan

  4. Bosentan: use injectable progestogen or a non-hormonal method; oral/implantable progestogens and combined methods are ineffective (CYP2C9/3A4 induction)

  5. LNG-IUS 99.8% effective > sterilisation 99.5%; both IUD and IUS can be inserted while anticoagulated and at any point in the cycle

  6. Copper IUD works immediately; LNG-IUS immediate only if inserted within 7 days of a period — otherwise 7 days of barrier cover

  7. Vasovagal bradycardia after insertion in 1.8% (Farmer & Webb, n=545); have atropine, adrenaline and oxygen ready. High-risk cardiac women: insert in hospital with cardiac monitoring and cardiac anaesthetic back-up

  8. Intrauterine contraception is UKMEC 4 in Fontan circulation and pulmonary vascular disease; IV antibiotic prophylaxis needed for previous endocarditis or prosthetic valves

Typical-use failure in first year

Vasectomy 0.15% · LNG-IUS 0.2% · sterilisation 0.5% · copper IUD <0.8% Diaphragm/cap + spermicide 12% · male condom 18%

Female condom 22% · withdrawal 22% · rhythm/calendar 24% — not suitable in cardiac disease

Abbreviation Key

  • WHOMEC — WHO Medical Eligibility Criteria for Contraceptive Use
  • IUS — levonorgestrel intrauterine system
  • UKMEC — UK Medical Eligibility Criteria for Contraceptive Use
  • VTE — venous thromboembolism
  • FSRH — Faculty of Sexual and Reproductive Healthcare
  • MI — myocardial infarction
  • LARC — long-acting reversible contraception
  • DOAC — direct oral anticoagulant
  • COC — combined oral contraceptive
  • INR — international normalised ratio
  • POP — progestogen-only pill
  • STI — sexually transmitted infection
  • IUD — (copper) intrauterine device
  • BMD — bone mineral density

Source: Jakes AD, Coad F, Nelson-Piercy C. A review of contraceptive methods for women with cardiac disease. The Obstetrician & Gynaecologist 2018;20:113–120. doi:10.1111/tog.12446

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free